1. Keep life flowing

    The foundation of our corporate culture is the awareness of the social value of plasma processing for the treatment of extremely severe and debilitating diseases, such as haemophilia and immune deficiencies.

    We invest in people, innovation and research to support the medical and scientific communities and the institutional patient communities worldwide, for ongoing product and process improvement, to give our contribution to making treatments widely available.

News

  1. 17-04-2014

    Over the last few days, Kedrion Group SpA successfully completed the issuance of senior, unsecured and unrated bonds of 300 million euros, due in April 2019.

  2. 16-04-2014

    A 425 million euros turnover with a 12% rise on 2012; global sales accounting for 66% of the overall turnover; a 25% EBITDA, 4 points more than in the previous financial year; a net profit of 34 mi

Biological Safety Center - BioSC

The Biological Safety Centre (BioSC) is a structure of the  Kedrion group dedicated to virus and prions safety studies.